|
1
|
Bhattacharjee N, Barma S, Konwar N,
Dewanjee S and Manna P: Mechanistic insight of diabetic nephropathy
and its pharmacotherapeutic targets: An update. Eur J Pharmacol.
791:8–24. 2016.PubMed/NCBI View Article : Google Scholar
|
|
2
|
Tung CW, Hsu YC, Shih YH, Chang PJ and Lin
CL: Glomerular mesangial cell and podocyte injuries in diabetic
nephropathy. Nephrology (Carlton). 23 (Suppl 4):S32–S37.
2018.PubMed/NCBI View Article : Google Scholar
|
|
3
|
Kawanami D, Matoba K and Utsunomiya K:
Signaling pathways in diabetic nephropathy. Histol Histopathol.
31:1059–1067. 2016.PubMed/NCBI View Article : Google Scholar
|
|
4
|
Huebschmann AG, Regensteiner JG, Vlassara
H and Reusch JE: Diabetes and advanced glycoxidation end products.
Diabetes Care. 29:1420–1432. 2006.PubMed/NCBI View Article : Google Scholar
|
|
5
|
Bellier J, Nokin MJ, Larde E, Karoyan P,
Peulen O, Castronovo V and Bellahcène A: Methylglyoxal, a potent
inducer of AGEs, connects between diabetes and cancer. Diabetes Res
Clin Pract. 148:200–211. 2019.PubMed/NCBI View Article : Google Scholar
|
|
6
|
Rehman S, Faisal M, Alatar AA and Ahmad S:
Physico-chemical changes induced in serum proteins,
immunoglobulin-G and fibrinogen by reactive carbonyl species,
Methylglyoxal. Curr Protein Pept Sci. 21:916–923. 2019.PubMed/NCBI View Article : Google Scholar
|
|
7
|
Ott C, Jacobs K, Haucke E, Navarrete
Santos A, Grune T and Simm A: Role of advanced glycation end
products in cellular signaling. Redox Biol. 2:411–429.
2014.PubMed/NCBI View Article : Google Scholar
|
|
8
|
Gruden G, Perin PC and Camussi G: Insight
on the pathogenesis of diabetic nephropathy from the study of
podocyte and mesangial cell biology. Curr Diabetes Rev. 1:27–40.
2005.PubMed/NCBI View Article : Google Scholar
|
|
9
|
Thallas-Bonke V, Thorpe SR, Coughlan MT,
Fukami K, Yap FY, Sourris KC, Penfold SA, Bach LA, Cooper ME and
Forbes JM: Inhibition of NADPH oxidase prevents advanced glycation
end product-mediated damage in diabetic nephropathy through a
protein kinase C-alpha-dependent pathway. Diabetes. 57:460–469.
2008.PubMed/NCBI View Article : Google Scholar
|
|
10
|
Rios JL, Francini F and Schinella GR:
Natural products for the treatment of type 2 diabetes mellitus.
Planta Med. 81:975–994. 2015.PubMed/NCBI View Article : Google Scholar
|
|
11
|
Choudhury H, Pandey M, Hua CK, Mun CS,
Jing JK, Kong L, Ern LY, Ashraf NA, Kit SW, Yee TS, et al: An
update on natural compounds in the remedy of diabetes mellitus: A
systematic review. J Tradit Complement Med. 8:361–376.
2018.PubMed/NCBI View Article : Google Scholar
|
|
12
|
Seo E, Oh YS, Kim D, Lee MY, Chae S and
Jun HS: Protective role of Psoralea corylifolia L. seed
extract against hepatic mitochondrial dysfunction induced by
oxidative stress or aging. Evid Based Complement Alternat Med.
2013(678028)2013.PubMed/NCBI View Article : Google Scholar
|
|
13
|
Heo J: Donguibogam. Namsandang, Seoul,
1980 (original work published, 1610) (In Korean).
|
|
14
|
Khushboo PS, Jadhav VM, Kadam VJ and Sathe
NS: Psoralea corylifolia Linn.-‘Kushtanashini’. Pharmacogn
Rev. 4:69–76. 2010.
|
|
15
|
Seo E, Kang H, Oh YS and Jun HS:
Psoralea corylifolia L. seed extract attenuates diabetic
nephropathy by inhibiting renal fibrosis and apoptosis in
streptozotocin-induced diabetic mice. Nutrients.
9(828)2017.PubMed/NCBI View Article : Google Scholar
|
|
16
|
Seo E, Oh YS and Jun HS: Psoralea
corylifolia L. seed extract attenuates nonalcoholic fatty liver
disease in high-fat diet-induced obese mice. Nutrients.
8(83)2016.PubMed/NCBI View Article : Google Scholar
|
|
17
|
Adisakwattana S, Thilavech T and Chusak C:
Mesona Chinensis Benth extract prevents AGE formation and
protein oxidation against fructose-induced protein glycation in
vitro. BMC Complement Altern Med. 14(130)2014.PubMed/NCBI View Article : Google Scholar
|
|
18
|
Sharaf H, Matou-Nasri S, Wang Q, Rabhan Z,
Al-Eidi H, Al Abdulrahman A and Ahmed N: Advanced glycation
endproducts increase proliferation, migration and invasion of the
breast cancer cell line MDA-MB-231. Biochim Biophys Acta.
1852:429–441. 2015.PubMed/NCBI View Article : Google Scholar
|
|
19
|
Chiang CK, Wang CC, Lu TF, Huang KH, Sheu
ML, Liu SH and Hung KY: Involvement of endoplasmic reticulum
stress, autophagy, and apoptosis in advanced glycation end
products-induced glomerular mesangial cell injury. Sci Rep.
6(34167)2016.PubMed/NCBI View Article : Google Scholar
|
|
20
|
Jiang W, Wang R, Liu D, Zuo M, Zhao C,
Zhang T and Li W: Protective effects of kaempferitrin on advanced
glycation end products induce mesangial cell apoptosis and
oxidative stress. Int J Mol Sci. 19(3334)2018.PubMed/NCBI View Article : Google Scholar
|
|
21
|
Thomasova D and Anders HJ: Cell cycle
control in the kidney. Nephrol Dial Transplant. 30:1622–1630.
2015.PubMed/NCBI View Article : Google Scholar
|
|
22
|
Koulis C, Watson AMD, Gray SP and
Jandeleit-Dahm KA: Linking RAGE and Nox in diabetic micro- and
macrovascular complications. Diabetes Metab. 41:272–281.
2015.PubMed/NCBI View Article : Google Scholar
|
|
23
|
Sedeek M, Callera G, Montezano A, Gutsol
A, Heitz F, Szyndralewiez C, Page P, Kennedy CR, Burns KD, Touyz RM
and Hébert RL: Critical role of Nox4-based NADPH oxidase in
glucose-induced oxidative stress in the kidney: Implications in
type 2 diabetic nephropathy. Am J Physiol Renal Physiol.
299:F1348–F1358. 2010.PubMed/NCBI View Article : Google Scholar
|
|
24
|
Ha H and Lee HB: Oxidative stress in
diabetic nephropathy: Basic and clinical information. Curr Diab
Rep. 1:282–287. 2001.PubMed/NCBI View Article : Google Scholar
|
|
25
|
Scindia YM, Deshmukh US and Bagavant H:
Mesangial pathology in glomerular disease: Targets for therapeutic
intervention. Adv Drug Deliv Rev. 62:1337–1343. 2010.PubMed/NCBI View Article : Google Scholar
|
|
26
|
Schlöndorff D and Banas B: The mesangial
cell revisited: No cell is an island. J Am Soc Nephrol.
20:1179–1187. 2009.PubMed/NCBI View Article : Google Scholar
|
|
27
|
Rhee SY and Kim YS: The role of advanced
glycation end products in diabetic vascular complications. Diabetes
Metab J. 42:188–195. 2018.PubMed/NCBI View Article : Google Scholar
|
|
28
|
Lee EJ, Kang MK, Kim DY, Kim YH, Oh H and
Kang YH: Chrysin inhibits advanced glycation end products-induced
kidney fibrosis in renal mesangial cells and diabetic kidneys.
Nutrients. 10(882)2018.PubMed/NCBI View Article : Google Scholar
|
|
29
|
Qiu YY, Tang LQ and Wei W: Berberine
exerts renoprotective effects by regulating the AGEs-RAGE signaling
pathway in mesangial cells during diabetic nephropathy. Mol Cell
Endocrinol. 443:89–105. 2017.PubMed/NCBI View Article : Google Scholar
|
|
30
|
Bourajjaj M, Stehouwer CD, van Hinsbergh
VW and Schalkwijk CG: Role of methylglyoxal adducts in the
development of vascular complications in diabetes mellitus. Biochem
Soc Trans. 31:1400–1402. 2003.PubMed/NCBI View Article : Google Scholar
|
|
31
|
Sherr CJ: Mammalian G1 cyclins. Cell.
73:1059–1065. 1993.PubMed/NCBI View Article : Google Scholar
|
|
32
|
Haberstroh U, Zahner G, Disser M, Thaiss
F, Wolf G and Stahl RA: TGF-beta stimulates rat mesangial cell
proliferation in culture: Role of PDGF beta-receptor expression. Am
J Physiol. 264:F199–F205. 1993.PubMed/NCBI View Article : Google Scholar
|
|
33
|
Lang S, Hartner A, Sterzel RB and
Schöcklmann HO: Requirement of cyclin D1 in mesangial cell
mitogenesis. J Am Soc Nephrol. 11:1398–1408. 2000.PubMed/NCBI View Article : Google Scholar
|
|
34
|
Schöcklmann HO, Lang S and Sterzel RB:
Regulation of mesangial cell proliferation. Kidney Int.
56:1199–1207. 1999.PubMed/NCBI View Article : Google Scholar
|
|
35
|
Sureshbabu A, Muhsin SA and Choi ME: TGF-β
signaling in the kidney: Profibrotic and protective effects. Am J
Physiol Renal Physiol. 310:F596–F606. 2016.PubMed/NCBI View Article : Google Scholar
|
|
36
|
Yu L, Border WA, Huang Y and Noble NA:
TGF-beta isoforms in renal fibrogenesis. Kidney Int. 64:844–856.
2003.PubMed/NCBI View Article : Google Scholar
|
|
37
|
Rajaram RD, Dissard R, Jaquet V and de
Seigneux S: Potential benefits and harms of NADPH oxidase type 4 in
the kidneys and cardiovascular system. Nephrol Dial Transplant.
34:567–576. 2019.PubMed/NCBI View Article : Google Scholar
|
|
38
|
Takac I, Schröder K, Zhang L, Lardy B,
Anilkumar N, Lambeth JD, Shah AM, Morel F and Brandes RP: The
E-loop is involved in hydrogen peroxide formation by the NADPH
oxidase Nox4. J Biol Chem. 286:13304–13313. 2011.PubMed/NCBI View Article : Google Scholar
|
|
39
|
Ratliff BB, Abdulmahdi W, Pawar R and
Wolin MS: Oxidant mechanisms in renal injury and disease. Antioxid
Redox Signal. 25:119–146. 2016.PubMed/NCBI View Article : Google Scholar
|
|
40
|
Iglesias-De La Cruz MC, Ruiz-Torres P,
Alcamí J, Díez-Marqués L, Ortega-Velázquez R, Chen S,
Rodríguez-Puyol M, Ziyadeh FN and Rodríguez-Puyol D: Hydrogen
peroxide increases extracellular matrix mRNA through TGF-beta in
human mesangial cells. Kidney Int. 59:87–95. 2001.PubMed/NCBI View Article : Google Scholar
|
|
41
|
Fukami K, Taguchi K, Yamagishi S and Okuda
S: Receptor for advanced glycation endproducts and progressive
kidney disease. Curr Opin Nephrol Hypertens. 24:54–60.
2015.PubMed/NCBI View Article : Google Scholar
|
|
42
|
Sanz AB, Sanchez-Niño MD, Ramos AM, Moreno
JA, Santamaria B, Ruiz-Ortega M, Egido J and Ortiz A: NF-kappaB in
renal inflammation. J Am Soc Nephrol. 21:1254–1262. 2010.PubMed/NCBI View Article : Google Scholar
|
|
43
|
Yang J, Zeng Z, Wu T, Yang Z, Liu B and
Lan T: Emodin attenuates high glucose-induced TGF-β1 and
fibronectin expression in mesangial cells through inhibition of
NF-κB pathway. Exp Cell Res. 319:3182–3189. 2013.PubMed/NCBI View Article : Google Scholar
|
|
44
|
Wang BF, Xu HS, Li YJ, Ye RG, Kong QY and
Yu XQ: Role of Akt/NF-kappa B signal transduction pathway in murine
glomerular mesangial cell proliferation induced by immune complex.
Xi Bao Yu Fen Zi Mian Yi Xue Za Zhi. 20:314–318. 2004.PubMed/NCBI(In Chinese).
|
|
45
|
Truong CS, Seo E and Jun HS: Psoralea
corylifolia L. seed extract attenuates methylglyoxal-induced
insulin resistance by inhibition of advanced glycation end product
formation. Oxid Med Cell Longev. 2019(4310319)2019.PubMed/NCBI View Article : Google Scholar
|
|
46
|
Sen Z, Weida W, Jie M, Li S, Dongming Z
and Xiaoguang C: Coumarin glycosides from Hydrangea
paniculata slow down the progression of diabetic nephropathy by
targeting Nrf2 anti-oxidation and smad2/3-mediated profibrosis.
Phytomedicine. 57:385–395. 2019.PubMed/NCBI View Article : Google Scholar
|
|
47
|
Zhang S, Xin H, Li Y, Zhang D, Shi J, Yang
J and Chen X: Skimmin, a coumarin from Hydrangea paniculata,
slows down the progression of membranous glomerulonephritis by
anti-inflammatory effects and inhibiting immune complex deposition.
Evid Based Complement Alternat Med. 2013(819296)2013.PubMed/NCBI View Article : Google Scholar
|
